HALO Sale Disclosure
Torley Helen · SEC Form 4 · Filed Sep 11, 2026
Sale
Calculated transaction value
$711.19K
Torley Helen President And CEO
HALO
Transaction date
Sep 9, 2026
Public filing date
Sep 12, 2026
Filing lag
Filed 3 days later
HALO daily price context
Close on/before transaction
$107.39
Sep 9, 2026
Close before public filing
$107.2
Sep 11, 2026
Return since public filing
0.0%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 6,596 shares @ $107.82
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001159036-26-000119
Filing cohort
Transactions in this filing
Showing 13 of 13
Trades
13
Issuers
1
Estimated value
$8.65M
Buys / sales
0 / 7
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Halozyme Therapeutics, Inc. HALO | Sale | Sep 11, 2026 | $1.66M |
| Halozyme Therapeutics, Inc. HALO | Exercise | Sep 11, 2026 | $368.2K |
| Halozyme Therapeutics, Inc. HALO | Exercise | Sep 11, 2026 | $368.2K |
| Halozyme Therapeutics, Inc. HALO | Sale | Sep 11, 2026 | $484.83K |
| Halozyme Therapeutics, Inc. HALO | Sale | Sep 10, 2026 | $582.23K |
| Halozyme Therapeutics, Inc. HALO | Exercise | Sep 10, 2026 | $368.2K |
| Halozyme Therapeutics, Inc. HALO | Sale | Sep 10, 2026 | $1.56M |
| Halozyme Therapeutics, Inc. HALO | Exercise | Sep 10, 2026 | $368.2K |
| Halozyme Therapeutics, Inc. HALO | Sale | Sep 9, 2026 | $10.87K |
| Halozyme Therapeutics, Inc. HALO | Exercise | Sep 9, 2026 | $368.2K |
| Halozyme Therapeutics, Inc. HALO | Sale | Sep 9, 2026 | $1.43M |
| Halozyme Therapeutics, Inc. HALO Current | Sale | Sep 9, 2026 | $711.19K |
| Halozyme Therapeutics, Inc. HALO | Exercise | Sep 9, 2026 | $368.2K |